Stocks Health care HTFL
NASDAQ · Health careHeartflow, Inc. (HTFL)
Heartflow, Inc. brought in $212.1M of revenue over the twelve months to June 30, 2026. It posted a net loss of $118.4M. In fiscal 2025 capital spending exceeded operating cash flow by $59M. At June 30, 2026 it held $34.4M in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 13, 2026.
Key facts about Heartflow, Inc.
- Net worth
- Heartflow, Inc. has a market value (market cap) of $4.9B at the latest share price, and shareholders' equity of $279.7M on its balance sheet at June 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
- Revenue and profit
- In fiscal 2025 revenue was $176M (+39.9% year on year), with a net loss of $116.8M. Over the 12 months to June 30, 2026: revenue $212.1M, net loss $118.4M.
- Cash flow
- In fiscal 2025 operations used $54M of cash.
- Latest report
- The latest periodic report (quarterly report, 10-Q) was filed with the SEC on August 13, 2026 and covers the period to June 30, 2026. Open on SEC EDGAR
- Next earnings report
- Heartflow, Inc.'s next report is expected around November 11, 2026. That is an estimate from its filing rhythm, not a date the company has announced.
What Heartflow, Inc. does
Heartflow, Inc. is registered with the SEC under industry code SIC 3841 (Surgical & Medical Instruments & Apparatus). Its shares trade on NASDAQ under the ticker HTFL.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | $176M | -$116.8M | -$3.17 | -$59M |
| 2025 | $125.8M | -$96.4M | -$17.98 | -$73.4M |
| 2023 | $87.2M | -$95.7M | -$25.32 | -$82.5M |
Earnings: every quarter and the next report date
Full financial statements: income, balance sheet and cash flow
Where HTFL ranks in Health care
Latest SEC filings
What Heartflow, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- August 14, 2026Passive stake changed SCHEDULE 13G/A
- August 13, 2026Quarterly report 10-Q · period to June 30, 2026Revenue rose 48% to $64.1M versus the same quarter last year; diluted EPS -$0.18 versus -$1.46.
- August 13, 2026Passive stake changed SCHEDULE 13G/A
- August 13, 2026
- August 6, 2026Passive stake changed SCHEDULE 13G/A
- July 28, 2026Passive stake (5% or more) SCHEDULE 13G
- June 18, 2026
- May 15, 2026Passive stake changed SCHEDULE 13G/A
- May 14, 2026Quarterly report 10-Q · period to March 31, 2026Revenue rose 41% to $52.6M versus the same quarter last year; diluted EPS -$0.32 versus -$5.25.
- May 14, 2026
Insider trades
What the people running Heartflow, Inc. did with its shares, from the Form 4 filings they must send the SEC within two business days.
Insiders sold $14.9M worth of shares in the last 90 days and bought none on the open market. All of the selling was pre-planned under Rule 10b5-1 trading plans.
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| October 22, 2026 | Rogers CampbellChief Medical Officer | Exercised options | 12,329 | $102.7K |
| October 22, 2026 | Rogers CampbellChief Medical Officer | Exercised options | 5,101 | $11.3K |
| October 22, 2026 | Rogers CampbellChief Medical Officer | Soldpre-planned (10b5-1) | 23,933 | $1.3M |
| October 12, 2026 | Farquhar John C.M.Chief Executive Officer, Director | Soldpre-planned (10b5-1) | 38,900 | $1.9M |
| September 18, 2026 | Rogers CampbellChief Medical Officer | Exercised options | 12,329 | $102.7K |
| September 18, 2026 | Rogers CampbellChief Medical Officer | Exercised options | 850 | $1.9K |
| September 18, 2026 | Rogers CampbellChief Medical Officer | Soldpre-planned (10b5-1) | 19,682 | $987.1K |
| September 18, 2026 | Verghese VikramChief Financial Officer | Soldpre-planned (10b5-1) | 16,766 | $850.9K |
Who owns HTFL
Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.
5% holders
| Holder | Of class | Filed |
|---|---|---|
| BCLS Fund III Investments, LP13G, passive | 9.8% | August 14, 2026 |
| Wellington Management Group LLP13G, passive with 3 related filers | 9.1% | August 13, 2026 |
| Fmr LLC13G, passive with 1 related filers | 5.7% | November 5, 2025 |
Largest institutional holders
Positions that investment managers reported on Form 13F for the quarter ended June 30, 2026, largest first, with the change on the quarter ended March 31, 2026. Managers file 13F up to 45 days after a quarter ends. 193 managers reported a position.
| Holder | Shares | Change on quarter |
|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 8,448,158 | -2,000,000 |
| Wellington Management Group Llp | 7,864,226 | -4,118,057 |
| BlackRock, Inc. | 5,197,747 | +3,735,163 |
| Fmr LLC | 4,820,944 | -576,858 |
| Vanguard Portfolio Management LLC | 3,584,428 | +1,538,490 |
| Bamco Inc | 3,225,133 | -602,398 |
| Vanguard Capital Management LLC | 2,753,206 | +859,711 |
| Jupiter Topco LLC | 2,419,336 | new |
| Invesco Ltd. | 2,298,718 | +385,628 |
| Point72 Asset Management, L.P. | 1,721,279 | +1,182,928 |
| Summit Partners Public Asset Management, LLC | 1,694,651 | +802,558 |
| Alliancebernstein L.P. | 1,924,268 | +699,942 |
| State Street Corp | 1,465,895 | +1,015,345 |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 1,465,650 | +50,822 |
| Geode Capital Management, LLC | 1,360,391 | +818,732 |
| Nuveen, LLC | 1,353,168 | +1,329,929 |
| Morgan Stanley | 1,054,889 | +202,957 |
| UBS Group AG | 975,510 | +546,426 |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | 931,160 | new |
| Millennium Management LLC | 922,893 | -170,524 |
Insiders
9 insiders reported holding 9,745,118 shares in total, about $543.8M at the last price.
| Holder | Shares |
|---|---|
| Bain Capital Life Sciences Investors, LLC10% owner | 8,448,1588,448,158 held indirectly |
| Lightcap Jeffrey CDirector | 293,681 |
| Farquhar John C.M.Chief Executive Officer, Director | 283,014 |
| Weldon William CDirector | 243,931 |
| Barabe Timothy CDirector | 188,231 |
| Verghese VikramChief Financial Officer | 155,183 |
| Rogers CampbellChief Medical Officer | 73,453 |
| Jones Marie L.Chief Accounting Officer | 32,176 |
| Cullivan Julie ADirector | 27,291 |
Questions about HTFL
What does Heartflow, Inc. do?
Heartflow, Inc. is a company in the Health care sector, listed on NASDAQ as HTFL. Its shares trade on NASDAQ under the ticker HTFL.
What is Heartflow, Inc.'s net worth?
Heartflow, Inc. has a market value (market cap) of $4.9B at the latest share price, and shareholders' equity of $279.7M on its balance sheet at June 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
Is Heartflow, Inc. profitable?
No. Over the twelve months to June 30, 2026 it reported a net loss of $118.4M on revenue of $212.1M.
How much revenue does Heartflow, Inc. make?
Over the twelve months to June 30, 2026 Heartflow, Inc. reported revenue of $212.1M.
When did Heartflow, Inc. last report?
Its most recent periodic report is the quarterly report (10-Q) filed on August 13, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the planned insider sale from November 9, 2026.
When is Heartflow, Inc.'s next earnings report?
Heartflow, Inc.'s next report is expected around November 11, 2026. That is an estimate from its filing rhythm, not a date the company has announced.
Similar companies
Compare HTFL with
Follow HTFL
Get an email when Heartflow, Inc. files with the SEC: results, executive changes, material agreements and annual reports.
Where the numbers come from
Financial figures are the values Heartflow, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.